Natriuretic Peptides Synthesis and Secretion Profiles during the Evolution of Cardiac Hypertrophy in DOCA-Salt Hypertensive Rats

pp. 493-499

Authors

  • Carolina S. Cerrudo Chair of Pathophysiology, INFIBIOC (Instituto de Fisiopatología y Bioquímica Clínica), School of Pharmacy and Biochemistry, University of Buenos Aires, CONICET
  • Martín Rodríguez Fermepin Chair of Pathophysiology, INFIBIOC (Instituto de Fisiopatología y Bioquímica Clínica), School of Pharmacy and Biochemistry, University of Buenos Aires, CONICET
  • Susana Cavallero Chair of Pathophysiology, INFIBIOC (Instituto de Fisiopatología y Bioquímica Clínica), School of Pharmacy and Biochemistry, University of Buenos Aires, CONICET
  • Silvia Saucedo Chair of Pathophysiology, INFIBIOC (Instituto de Fisiopatología y Bioquímica Clínica), School of Pharmacy and Biochemistry, University of Buenos Aires, CONICET
  • Cecilia M. Hertig Institute for Research in Genetic Engineering and Molecular Biology (INGEBI)-CONICET; Argentina
  • Belisario E. Fernández Chair of Pathophysiology, INFIBIOC (Instituto de Fisiopatología y Bioquímica Clínica), School of Pharmacy and Biochemistry, University of Buenos Aires, CONICET

DOI:

https://doi.org/10.7775/rac.v79i6.1966

Keywords:

Atrial Natriuretic Peptides, ANP, Cardiac Hypertrophy

Abstract

The interactions between pressure and volume overload that occur in hypertension lead to different patterns of cardiac hypertrophy and to increase in natriuretic peptides (NPs). The profiles of ANP and BNP synthesis and secretion have been investigated in models of hypertension; however, the different evolution of these profiles during the acute and chronic periods of pressure overload-induced cardiac hypertrophy is still unknown. For this reason, we studied DOCA-salt treated Sprague-Dawley rats at weeks 2, 4, 6 and 12 and correlated the evolution of these profiles with cardiac hypertrophy and hypertension.

Cardiac hypertrophy had a positive correlation with ANP expression in the left ventricle and with ANP plasma levels. BNP expression increased after 4 weeks of treatment while BNP increased significantly after 6 weeks. In addition, BNP plasma levels increased only in the group treated for 12 weeks, while ANP plasma levels increased from week 2.

NP secretion has a differential response in the early stages of the development of cardiac hypertrophy induced by the DOCA-salt model, with early increase in ANP. As ANP levels were exceeded those of BNP in all the DOCA-salt groups, ANP might be considered a more specific marker of volume overload.

Published

2025-10-28

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)